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Pancreatoblastoma is a rare paediatric malignant neoplasm. The treatment of choice is complete surgical resection. However, it is often 
unresectable due to its large size, local infiltration or distant metastasis. Since the condition is rare, there is currently no standard treatment 
regimen. We outline the case of a 4-year-old child who presented with abdominal pain and distention, together with an enlarged liver and 
elevatedserumα-fetoproteinlevels.Imagingstudiesshowedthepresenceofanabnormalpancreatictumourandmultiplenodularlesions
intheliver,thebiopsiesfromwhichledtoadiagnosisofpancreatoblastoma.Inthiscase,thepatientreceivedcyclesofneoadjuvantche-
motherapy, combining cisplatin and doxorubicin. The patient subsequently underwent scheduled surgery in which the primary pancreatic 
lesionwasresected,obtainingacircumscribedandnodularspecimenmeasuring7×6cmandweighing150g.Giventheextentofthe
metastasis, the child is currently awaiting a liver transplant.










Pancreatoblastoma is the term given to rare malignant neoplasms [1] that mimic foetal pancreatic development at 7 weeks of gestation 
[2]. It tends toaffect young,predominantlymale, children, presenting clinically asanabdominalmass, abdominal painor obstructive
jaundice[3]. The rarity of the condition and the lack of specificity in its symptoms make pancreatoblastoma a real diagnostic challenge 
for oncologists and surgeons, especially since standardised guidelines are not available for this purpose [1, 4]. Since it is a biologically 
aggressiveneoplasm,itmaybeunresectableatthetimeofdiagnosis,insteadofrequiringneoadjuvantchemotherapytoshrinkthetumour.
Inlocalisedcases,completeresectionofthelesionisrequired.However,managementisproblematicwhentheneoplasiaspreadsoutside
of the pancreas or causes distant metastasis since, again, there is no standardised treatment regimen available [4]. To contribute to this 
field, we outline the case of a 4-year-old child with a pancreatoblastoma and multiple liver metastases at the time of diagnosis.
Clinical case
A 4-year-old male Caucasian patient with no prior family history of neoplasms presented in fair general condition with weight loss and loss of 




which showed irregular hepatomegaly with a heterogeneous echotexture due to the presence of multiple, randomly distributed echogenic 
nodules, suggestive of metastasis. The pancreas could not be evaluated. This was followed by an abdominal and pelvic CT scan with and 
without contrast dye: this showed a heterogeneous tumour in the body and tail of the pancreas that had defined borders, hypodense areas 
inside (suggestive of necrosis) and an apparent pseudocapsule. This measured: anteroposterior diameter 75 × transverse diameter 57 × 
longitude 101 mm, displacing the left kidney and the splenic artery in the head and rear directions, the left ureter in the dorsal direction and 
the bowel in the caudal direction. Enlarged heterogeneous liver, due to the presence of multiple hypodense nodules. The full body bone scan 
pathology did not show focal uptake. The adrenal glands showed no significant changes.
The patient’s condition deteriorated: he presented an acute abdomen requiring surgery, for which an exploratory laparotomy was per-
formed. This revealed a hepatic nodular lesion in the left lobe, with surface erosion and bleeding, from which biopsies were taken. The 
histopathological study with Haematoxylin–Eosin (H & E) staining showed limited liver trabeculae, infiltrated by a poorly differentiated 
malignant neoplastic proliferation consisting of medium-sized round or polygonal cells with large cytoplasma, with areas of necrosis and 
haemorrhage. Immunohistochemistry procedures were run, revealing neoplastic cells: positive for vimentin, Cytokeratin (AE1–AE3),
β-catenin,Ki-67(in80%oftheneoplasticnuclei)and,focally,carcinoembryonicantigen.Incontrast,thetestswerenegativeforneuron-
specific enolase, Chromogranin and Hep Par-1. The earlier findings, together with the patient’s clinical context, suggested liver metastasis 
due to pancreatoblastoma.
The patient went into intensive care and, upon returning to the ward, started a course of chemotherapy, using cisplatin 56 mg/m2 and 
doxorubicin 21 mg/m2.
Followingneoadjuvanttreatment,thepatientunderwentschedulesurgeryforexcisionofapancreatictumour.Thesurgicalapproachwas
through the lesser sac, locating it in the tail and body of the pancreas. We proceeded to the lower margin, releasing the relevant vessels, 
to the posterior for unaffected pancreatic tissue and, finally, to the upper margin respecting the splenic vessels. A circumscribed, nodular 
lesion of 7 × 6 cm and weighing 150 g was obtained in the aforementioned procedure (pancreatectomy of the body and tail). The site of 
incision had a yellowish surface with solid areas and a friable central section. Histological sections showed the presence of a pancreato-
blastoma, with large areas of necrosis and two residual peripheral nodules. Additional immunohistochemical techniques demonstrated the 
membranepositivityforE-cadherinandvascularendothelialgrowthfactor(VEGF).









Figure 1. (a) CT scan that shows enlarged, heterogeneous liver due to the presence of multiple hypodense nodules. (b) In the body and tail of 
pancreas, there was a heterogeneous tumour with defined boundaries and hypodense areas inside, suggestive of necrosis, together with an 
apparent pseudocapsula. (c) Macroscopic appearance of the pancreatic lesion measuring 7 × 6 cm and weighing 150 g, circumscribed, nodular 
with the congestive outer surface. (d) Yellowish cut surface with solid areas and friable central sector, necrotic.
Figure 2. (a) Histological image showing the biopsy of the liver nodules, at the start of the diagnostic process (H & E 200×). (b) In relation to the 
neoplastic proliferation, residual hepatic trabeculae were observed (H & E, 200×). (c) The immunohistochemical expression for Hep-Par1 was 
positive only in the liver parenchyma (immunohistochemistry, 200×). (d) Histological image showing the surgical resection of the pancreatic 
tumour, the characteristics of which were similar to those observed in the previous liver biopsy (H & E, 200×). (e) Neoplastic cells showed 
moderate anicocariosis, visible nucleoli and extensive, occasionally vacuolated, cytoplasm (H & E, 200×), which were positive for Cytokeratin 
(f). E-cadherin (g), Ki67 in 80% of the proliferation (h) and VEGF (i) (immunohistochemistry 200×). 
Discussion










bud as a result of abnormal embryological development [6, 7], which would explain why it is typically found at the head of the pancreas. 
However, it can sometimes be found in the tail of the pancreas [8].
Pancreatoblastomaaccountsfor0.2%ofallneoplasmsinthepancreas,beingmostfrequentamongchildren(meanageof5years)[9,10]. 
Inacohortstudy,itaccountedfor16%ofallpancreaticprimarymalignantneoplasmsamongchildren,withanaverageageatpresentation
of 5.5 years [11]. The aforementioned study also notes that it can occur within the context of a hereditary syndrome such as Beckwith–
WiedemannorFamilialadenomatouspolyposissyndrome,suggestingapathogenesisrelatedtoalterationsinchromosomes11and5,
respectively [3, 11].Itoriginatesintheepithelialcellsoftheexocrinesectionsofthepancreas,aswithadenocarcinoma,adenosquamous
carcinoma, acidic cell carcinoma and solid pseudopapillary tumour [12].Itsslowgrowthmeansthatitoftenoccursasalargeabdominal
mass, which usually hinders identification of the organ in which it originates [13].Furthermore,italsotendstopresentwithelevatedserum
levelsofα-fetoprotein[14]duetothecommonembryologicdevelopmentofthepancreasandliver,bothofwhichoriginateintheforegut.In
these circumstances, it can be used to indicate how well a patient is responding to treatment and to monitor progress [7, 15].
Macroscopically, the lesion is usually enclosed, lobed and solid with a heterogeneous, necrotic, haemorrhagic cut surface and a mean 
diameter that can reach up to 11 cm [16, 17]. Microscopically, the neoplasia is characterised by being richly cellular, cytologically uniform 
and organised in nests and islets, with a tendency to form acinar structures [2, 3, 6, 15]. An important feature of diagnostic value is the 
formation of whorled nests of scaly spindle cells (squamoid corpuscules), which exhibit occasional keratinisation, contributing to the dif-
ferential diagnosis of acinar cell carcinoma. Tumour stroma is relatively common, especially among children, which may eventually show 
heterologous elements such as bone or cartilage.
ImmunohistochemicaltechniquesshowdiffuseexpressionofCytokeratinmembrane(AE1–AE3)andepithelialmembraneantigen,while
in areas of acinar differentiation one tends to find typical pancreatic exocrine enzymes such as trypsin, chymotrypsin and lipase, the latter 
to a lesser extent [17]. Inaddition, insolidsectorswithoutclearacinardifferentiation,pancreatoblastomacandisplayimmunoreactivity
tochromogranin,synaptophysinandneuronalspecificenolase,whichhindersthedifferentialdiagnosisespeciallywithsmallbiopsies.In
thisregard,someauthorsconsiderthataberrantnuclearexpressionofβ-cateninandthelossofexpressionofE-cadherinmembraneare
characteristics of the solid pseudopapillary tumour of the pancreas, another factor that must be considered in the differential diagnosis [18]. 
VEGFisapro-angiogenicgrowthfactorinvolvednotonlyinnormalpancreaticdevelopmentbutalsointumourgrowthandmetastasis[19]. 
Inthecasestudypresented,theimmunohistochemicalexpressionwasintenseanddiffuseintheprimarypancreaticlesion,coincidingwith
the onset of metastasis.
InthestudyconductedbyBienet al [1], complete resection is the treatment of choice, whether it be at the time of diagnosis or following 
chemotherapytreatment(5-yearsurvivalrate:30%–50%).Inthisregard,theydonotconsidertheretobeacorrelationbetweentumoursize
and the ability to perform a complete resection nor between the tumour’s size and its progression. However, in cases where the tumour is 
technically unresectable, prior chemotherapy treatment is acceptable, with optimal response to the use of drugs such as cyclophospha-
mide, etoposide, cisplatin or doxorubicin [1, 12, 20].Inthesecases,radiotherapycouldalsoplayarole,althoughitsuseislimitedgiventhe
morbidity that may result, especially considering that patients with pancreatoblastoma are usually young children [1]. The study also raises 
the option of liver transplantation in those cases with massive metastasis on the liver [4].
Finally,theworkdonebyDhebriet al [21]outlinescertainfactorsinfluencingtheprognosisofpatientswithpancreatoblastoma.Univariate
analysis showed that the presence of synchronous or metachronous metastasis, unresectability of the lesion at the time of diagnosis and 
being over 16 years old worsen the prognosis. On the other hand, multivariate analysis found that complete surgical resection and the 
development of post-operative metastasis independently influence the long-term survival. The same is not true of local recurrences.
Conclusion












in cases with massive metastasis, liver transplantation. The case study illustrates the characteristics of the disease and the strategies currently 
available to approach a patient’s treatment.
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